Quantbot Technologies LP lessened its holdings in Core Laboratories Inc. (NYSE:CLB – Free Report) by 26.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,387 shares of the oil and gas company’s stock after selling 2,973 shares during the quarter. Quantbot Technologies LP’s holdings in Core Laboratories were worth $145,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. The Manufacturers Life Insurance Company boosted its holdings in Core Laboratories by 19.1% in the third quarter. The Manufacturers Life Insurance Company now owns 21,511 shares of the oil and gas company’s stock valued at $399,000 after purchasing an additional 3,457 shares in the last quarter. FMR LLC lifted its position in Core Laboratories by 182.9% in the third quarter. FMR LLC now owns 17,057 shares of the oil and gas company’s stock valued at $316,000 after acquiring an additional 11,028 shares during the last quarter. Captrust Financial Advisors acquired a new position in Core Laboratories in the third quarter valued at $997,000. State Street Corp grew its stake in Core Laboratories by 2.9% during the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock worth $36,597,000 after buying an additional 56,187 shares during the last quarter. Finally, Jane Street Group LLC grew its stake in Core Laboratories by 53.8% during the 3rd quarter. Jane Street Group LLC now owns 71,989 shares of the oil and gas company’s stock worth $1,334,000 after buying an additional 25,189 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.
Core Laboratories Stock Down 1.4 %
Core Laboratories stock opened at $15.30 on Monday. The stock has a market capitalization of $716.45 million, a price-to-earnings ratio of 23.18, a PEG ratio of 0.99 and a beta of 2.38. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The stock has a 50 day moving average of $16.44 and a two-hundred day moving average of $18.11. Core Laboratories Inc. has a twelve month low of $12.95 and a twelve month high of $25.13.
Core Laboratories Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Monday, February 10th were issued a $0.01 dividend. The ex-dividend date of this dividend was Monday, February 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.26%. Core Laboratories’s dividend payout ratio is currently 6.06%.
Wall Street Analyst Weigh In
Separately, Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and lifted their target price for the company from $15.00 to $16.00 in a report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating and four have given a hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $17.50.
Read Our Latest Stock Analysis on Core Laboratories
About Core Laboratories
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Recommended Stories
- Five stocks we like better than Core Laboratories
- 3 Dividend Kings To Consider
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Conference Calls and Individual Investors
- MarketBeat Week in Review – 03/24 – 03/28
- How to Use the MarketBeat Stock Screener
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.